New drug trial aims to save lives from devastating lung failure
Disease control
Recruiting now
This study is testing whether adding an experimental drug called recombinant human plasma gelsolin (rhu-pGSN) to standard hospital care can help patients with severe Acute Respiratory Distress Syndrome (ARDS) caused by infections like pneumonia. ARDS is a life-threatening conditi…
Phase: PHASE2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC